Lv3
292 积分 2024-09-03 加入
The Kidney in the Middle: KDIGO Guidelines Address Multiple Key Components of Cardiovascular-Kidney-Metabolic Syndrome
4天前
已关闭
Efficacy and safety of janagliflozin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled on diet and exercise: A multicentre, randomized, double‐blind, placebo‐controlled, Phase 3 trial
1个月前
已完结
Sabal serrulata extract (Strogen forte) in the treatment of symptomatic benign prostatic hyperplasia
2个月前
已完结
Serenoa repens for benign prostatic hyperplasia
2个月前
已完结
Time trends and regional variation in utilization of antidiabetic medicines in China, 2015–2022
3个月前
已完结
Ophthalmic Complications Associated With the Antidiabetic Drugs Semaglutide and Tirzepatide
4个月前
已完结
Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide
4个月前
已完结
Clinical practice guideline for the use of calcineurin inhibitors in the treatment of glomerular diseases in children(2026)
4个月前
已关闭
Prediction of janagliflozin pharmacokinetics in type 2 diabetes mellitus patients with liver cirrhosis or renal impairment using a physiologically based pharmacokinetic model
5个月前
已完结
Reduction in HbA1c with SGLT2 inhibitors vs. DPP-4 inhibitors as add-ons to metformin monotherapy according to baseline HbA1c: A systematic review of randomized controlled trials
6个月前
已完结
皖公网安备34019202002308
